Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
October 31, 2024 at 06:33 AM EDT
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.
